ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Shareholder Equity 2017–2025
ImmuCell Corporation annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- ImmuCell Corporation shareholder equity as of December 31, 2025: 27.1M, a 1.68% decrease year-over-year.
- ImmuCell Corporation shareholder equity for 2025 were 27.1M, a 1.68% decrease from 2024.
- ImmuCell Corporation shareholder equity for 2024 were 27.5M, a 10.10% increase from 2023.
- ImmuCell Corporation shareholder equity for 2023 were 25.0M, a 17.73% decrease from 2022.
- ImmuCell Corporation shareholder equity for 2022 were 30.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ImmuCell Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $27 |
| 2024 | $28 |
| 2023 | $25 |
| 2022 | $30 |
| 2021 | $33 |
| 2020 | $28 |
| 2019 | $29 |
| 2018 | $22 |
| 2017 | $24 |
ImmuCell Corporation Shareholder Equity — FAQ
ImmuCell Corporation (ICCC) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's shareholder equity history?
The chart and table above show ImmuCell Corporation's shareholder equity by year and by quarter, including the growth rate.